Revenue: As of FY2025, the actual value is USD 10.55 M.EPS: As of FY2025, the actual value is USD 0.46.<h3>Financial and Operational Metrics</h3><h4>Net Sales</h4>United-Guardian, Inc.’s net sales decreased by 13% from $12,181,971 in 2024 to $10,545,468 in 2025.<h4>Net Income</h4>Net income for United-Guardian, Inc. was $2,105,738 in 2025, down from $3,250,875 in 2024.<h4>Costs and Expenses</h4><ul><li>Cost of Sales: $5,404,328 in 2025 compared to $5,721,584 in 2024.</li><li>Operating Expenses: $2,434,148 in 2025 compared to $2,356,819 in 2024.</li><li>Research and Development: $463,644 in 2025 compared to $456,779 in 2024.</li><li>Total Costs and Expenses: $8,302,120 in 2025 compared to $8,535,182 in 2024.</li></ul><h4>Income from Operations</h4>Income from operations was $2,243,348 in 2025, a decrease from $3,646,789 in 2024.<h4>Other Income</h4><ul><li>Investment Income: $365,308 in 2025 compared to $434,679 in 2024.</li><li>Net Gain on Marketable Securities: $34,359 in 2025 compared to $26,989 in 2024.</li><li>Total Other Income: $399,667 in 2025 compared to $461,668 in 2024.</li></ul><h4>Income Before Provision for Income Taxes</h4>Income before provision for income taxes was $2,643,015 in 2025, down from $4,108,457 in 2024.<h4>Provision for Income Taxes</h4>Provision for income taxes was $537,277 in 2025 compared to $857,582 in 2024.<h4>Balance Sheet Data (as of December 31)</h4><ul><li>Current Assets: $12,201,397 in 2025 compared to $12,665,551 in 2024.</li><li>Deferred Tax Asset, Net: Not applicable in 2025 compared to $175,397 in 2024.</li><li>Property, Plant, and Equipment, Net: $907,182 in 2025 compared to $956,387 in 2024.</li><li>Total Assets: $13,108,579 in 2025 compared to $13,797,335 in 2024.</li><li>Current Liabilities: $1,669,321 in 2025 compared to $1,914,469 in 2024.</li><li>Deferred Tax Liability, Net: $207,246 in 2025 compared to Not applicable in 2024.</li><li>Total Liabilities: $1,876,567 in 2025 compared to $1,914,469 in 2024.</li><li>Stockholders’ Equity: $11,232,012 in 2025 compared to $11,882,866 in 2024.</li><li>Total Liabilities and Stockholders’ Equity: $13,108,579 in 2025 compared to $13,797,335 in 2024.</li></ul><h4>Segment Performance</h4><ul><li>Cosmetic Ingredients: Sales decreased in 2025 due to excess inventory held by the largest distributor, Ashland Specialty Ingredients (ASI), and reduced global demand, particularly in China, impacted by increased competition and tariffs.</li><li>Pharmaceuticals: Sales increased by 15% in 2025 compared to 2024, driven by higher sales to national drug wholesalers and a decrease in Medicare rebates.</li><li>Medical Lubricants: Sales increased by 4% in 2025 compared to 2024, attributed to greater demand from two large contract manufacturer customers in China.</li></ul><h3>Outlook / Guidance</h3>United-Guardian, Inc. initiated a new marketing strategy for Renacidin® in 2025, which received approval from two major pharmacy benefit managers, aiming to enhance patient access and support long-term commercial growth. The company is optimistic that this initiative, along with new marketing and distribution agreements for cosmetic ingredients entered into in 2025, will lead to increased sales in the coming years.

United-Guardian | 8-K: FY2025 Revenue: USD 10.55 M